The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s diabetic kidney disease market report forecasts the diabetic kidney disease market size to grow to $3.09 Billion by 2027, with a CAGR (compound annual growth rate) of more than 5%.

Learn More On The Diabetic Kidney Disease Market Report 2023 – https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Diabetic Kidney Disease Market Size Forecast
The global diabetic kidney disease market is expected to grow from $2.37 billion in 2022 to $2.51 billion in 2023 at a compound annual growth rate (CAGR) of 5.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global diabetic kidney disease market size is expected to reach $3.09 billion in 2027 at a CAGR of 5.4%.

North America held the largest diabetic kidney disease market share.

Key Diabetic Kidney Disease Market Driver ­– Rise In The Prevalence Of Chronic Kidney Disease
According to a report issued by the Centres for Disease Control and Prevention (CDC), a US-based public health body, more than 37 million people in the United States were predicted to have chronic kidney disease (CKD) in 2021. Furthermore, CKD is more common in those 65 and older, with 38% of the elderly suffering from some sort of renal impairment. As a result, the increased frequency of chronic kidney disease is propelling the diabetic kidney disease market ahead.

Request for A Sample Of The Global Diabetic Kidney Disease Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

Key Diabetic Kidney Disease Market Trend – Technological Advancement
Companies in the diabetic kidney disease market are embracing new technologies in order to maintain their market position. Bloom Diagnostics, a US-based diagnostics and healthcare equipment company, for example, announced the Bloom Kidney Test in August 2022, a new instrument that can be connected with the Bloom Smart System. The Bloom Kidney Test is a diagnostic test that measures cystatin C levels, which are a good predictor of kidney function. It divides kidney function into three categories: normal, mildly reduced, and reduced. The Bloom Smart System integrates test results with other pertinent health information, such as the patient’s medical history, lifestyle, and symptoms, using cloud-based algorithms and AI (artificial intelligence) technology.

Diabetic Kidney Disease Market Segment
1) By Type: Type 1 Diabetes, Type 2 Diabetes
2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments
3) By End User: Hospitals, Homecare, Speciality Centres, Other End Users

Diabetic Kidney Disease Market Major Players and Strategies
Major players in the diabetic kidney disease market are AstraZeneca, Pfizer Inc., Novartis AG, Bayer AG, Sanofi Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Sun Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma, Fresenius SE & Co. KGaA, F. Hoffmann-La Roche Ltd., Abbott Laboratories, Reata Pharmaceuticals, and Merck & Co.

Cincor Pharma Inc was acquired by AstraZeneca, a UK-based biotechnology and pharmaceutical business, for an undisclosed sum in January 2023. AstraZeneca’s cardiorenal pipeline will be strengthened by the addition of CinCor’s candidate medication, baxdrostat (CIN-107), an aldosterone synthase inhibitor (ASI) for blood pressure reduction in treatment-resistant hypertension. CinCor Pharma Inc. is a biopharmaceutical business established in the United States that specialises in the development of medications for the treatment of kidney disease.

The Diabetic Kidney Disease Global Market Report 2023 covers regional data on diabetic kidney disease market size, diabetic kidney disease market trends and drivers, opportunities, strategies, and diabetic kidney disease market competitor analysis. The countries covered in the diabetic kidney disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Diabetic kidney disease is a kind of renal illness caused by diabetes complications that arises when high blood sugar levels cause kidney damage. High blood glucose levels can damage the blood vessels of the kidneys, reducing their functioning.

View More Reports Related To The Diabetic Kidney Disease Market –
Kidney Cancer Drugs Global Market Report 2023
Diabetic Neuropathy Global Market Report 2023
Autoimmune Disease Diagnosis Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: